Centrum Onkologii Ziemi Lubelskiej
Centrum Onkologii Ziemi Lubelskiej is a public oncology hospital in Lublin, Poland — the only high-reference cancer center in the Lublin region — delivering comprehensive cancer diagnosis, treatment, and rehabilitation services funded primarily by the National Health Fund (NFZ).
- Company typePublic
- Founded1953
- HeadquartersLublin, Poland
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Centrum Onkologii Ziemi Lubelskiej does
Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli (COZL) is a public oncology hospital headquartered in Lublin, Poland, operating since 1953 as the only oncology facility in the Lublin region at the highest reference level under Poland's public healthcare system. The institution delivers comprehensive cancer care across 7 buildings, comprising 18+ inpatient wards, 30+ outpatient specialist clinics, and a full diagnostic stack that includes diagnostic imaging (MRI, CT, PET, ultrasound, mammography), a medical laboratory (1.6 million tests in 2023), a tumor pathology department (~25,000 preparations/year), nuclear medicine, and an oncology clinical trials center. Treatment modalities span surgical oncology, radiotherapy, brachytherapy, stereotactic radiosurgery (pioneered in Poland since 1989, with over 2,000 patients treated), chemotherapy, rehabilitation, and palliative care.
The technology base is anchored by a state-of-the-art radiotherapy fleet: 5 Elekta Versa HD linear accelerators, Radixact TomoTherapy, 2 Siemens tomographic simulators, the largest RayStation planning deployment in Poland (with machine learning-based clinical options), Varian HDR and Bebik HDR brachytherapy suites, the new Bravos Varian HDR (launched June 2022, 30 channels), and one of only two Brainlab ExacTrac stereotactic systems in the country. The endoscopy unit uses the Olympus EVIS X1 with 4K imaging, the only such installation in the Lublin region.
COZL is funded primarily through contracts with Poland's National Health Fund (NFZ), with a secondary fee-for-service stream for international and non-entitled patients. The hospital operates under the institutional oversight of the Marshal's Office of the Lublin Voivodeship, holds Ministry of Health Accreditation (No. 2026/4), ISO 9001:2015 certification, and the Wymagaj Jakości quality distinction (2025, ranking among 24 out of 1,000+ eligible facilities). It conducts teaching and research with the Medical University of Lublin and maintains collaborative partnerships with the University Children's Hospital and the Neurosurgery Clinic SPSK4 for pediatric radiotherapy and stereotactic radiosurgery respectively.
Centrum Onkologii Ziemi Lubelskiej firmographics
Firmographics- Name
- Centrum Onkologii Ziemi Lubelskiej
- Legal name
- Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli
- Website
- https://www.cozl.eu
- Company type
- Public
- Founded year
- 1953
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Centrum Onkologii Ziemi Lubelskiej is a public oncology hospital in Lublin, Poland — the only high-reference cancer center in the Lublin region — delivering comprehensive cancer diagnosis, treatment, and rehabilitation services funded primarily by the National Health Fund (NFZ).
- Ownership category
- akta.pro rank
Centrum Onkologii Ziemi Lubelskiej industry classification
Industry- Product category
- Oncology Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (62111)
- SIC
- Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro industry
- Oncology & Cancer Specialty HospitalsHealthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty CareMedical OncologyHospital-Integrated Cancer Centers (Acute Oncology Programs)Surgical OncologyGynecologic OncologyThoracic (Lung) Oncology
Keywords
Where Centrum Onkologii Ziemi Lubelskiej is headquartered
LocationHeadquarters
- HQ city
- Lublin
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
Centrum Onkologii Ziemi Lubelskiej business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- National Health Fund (NFZ) Contracts: COZL operates as a public healthcare institution financed primarily through contracts with Poland's Narodowy Fundusz Zdrowia (NFZ). All core oncology services — inpatient care, outpatient clinics, diagnostics, radiotherapy, surgery, chemotherapy — are reimbursed under NFZ public healthcare funding.
- Fee-for-Service for Non-Entitled Patients: International patients and others not entitled to free NFZ healthcare pay according to a published fee schedule covering consultations, procedures, inpatient stays, diagnostics, and other services.
- Medical Diagnostic and Laboratory Services: The Medyczne Laboratorium Diagnostyczne performs approximately 1.6 million tests annually (2023) for COZL and external referrers. Services include hematology, biochemistry, immunology, serology, microbiology, and molecular diagnostics.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | NFZ-funded services (public healthcare patients) |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels4 records
Centrum Onkologii Ziemi Lubelskiej product offering
Product offeringCore offering
Centrum Onkologii Ziemi Lubelskiej is a public oncology hospital providing comprehensive cancer diagnosis, treatment, and follow-up care. Services include surgical oncology, radiotherapy (teleradiotherapy, brachytherapy, stereotactic radiosurgery), chemotherapy, nuclear medicine, diagnostic imaging (MRI, CT, PET, ultrasound, mammography), clinical pathology, genetics, rehabilitation, and palliative care, delivered across inpatient wards, outpatient specialist clinics, and diagnostic departments at its Lublin campus.
Product overview
Centrum Onkologii Ziemi Lubelskiej is an oncology hospital providing comprehensive cancer care through an integrated network of specialized departments and units. The offering consists of inpatient hospital wards (surgery, gynecology, hematology, cardiology, radiotherapy, urology, ENT, endocrinology, orthopedics, plastic surgery), diagnostic departments (pathology, medical laboratory, diagnostic imaging, nuclear medicine, medical physics), treatment units (brachytherapy, teleradiotherapy, stereotactic radiosurgery, endoscopy), specialized centers (colorectal cancer unit, breast cancer team, clinical trials center, rehabilitation center, prevention center), and a network of outpatient specialist clinics. The hospital operates 7 buildings and serves as the only oncology facility in the Lublin region with the highest level of reference care.
Differentiator
Problem solved
Functional benefit
Products and services
- Pracownia Teleradioterapii (External Beam Radiotherapy)
- Pracownia Brachyterapii (Brachytherapy)
- Pracownia Stereotaksji (Stereotactic Radiosurgery/Radiotherapy)
- Pracownia Endoskopowa (Endoscopy Unit)
- Centrum Kompleksowego Leczenia Raka Jelita Grubego (Colorectal Cancer Unit)
- Zakład Patologii Nowotworów (Tumor Pathology Department)
- Medyczne Laboratorium Diagnostyczne (Medical Diagnostic Laboratory)
- Zakład Diagnostyki Obrazowej (Diagnostic Imaging Department)
- Zakład Medycyny Nuklearnej (Nuclear Medicine Department)
- Zespół Poradni Specjalistycznych (Team of Specialist Clinics)
- Onkologiczne Centrum Badań Klinicznych COZL (Oncology Clinical Trials Center)
- Ośrodek Profilaktyki Nowotworów i Promocji Zdrowia (Cancer Prevention Center)
- Ośrodek Rehabilitacji (Rehabilitation Center)
- Zespół Leczenia Raka Piersi (Breast Cancer Treatment Team)
- Apteka Szpitalna (Hospital Pharmacy)
Quantifiable outcome
- Over 3,000 radiotherapy patients treated annually across all tumor locations
- +3 more outcomes
Companies that use Centrum Onkologii Ziemi Lubelskiej
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles2 records
Centrum Onkologii Ziemi Lubelskiej technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Centrum Onkologii Ziemi Lubelskiej partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor, moderate and core.
- Fundacja Onkologii Lubelskiej (Lublin Oncology Foundation)minorCOZL collaborates with the Fundacja Onkologii Lubelskiej (Lublin Oncology Foundation), a public benefit organization that supports cancer patients and the hospital's mission.
- Lubelskie Stowarzyszenie Amazonek (Lublin Breast Cancer Survivors Association)minorPartnership with the Lublin Breast Cancer Survivors Association (Lubelskie Stowarzyszenie Amazonek) providing peer support and resources for breast cancer patients.
- Polskie Towarzystwo Onkologiczne Oddział w Lublinie (Polish Oncological Society, Lublin Branch)minorCOZL hosts and collaborates with the Lublin branch of the Polish Oncological Society (PTO), supporting scientific exchange and professional development in oncology.
- Uniwersytet Medyczny w Lublinie (Medical University of Lublin)moderateCOZL conducts teaching and research activities in collaboration with the Medical University of Lublin. The Brachytherapy Department and Zakład Patologii Nowotworów engage in didactic-scientific activities within this cooperation.
- PTDL Oddział Lubelski (Polish Society of Laboratory Diagnostics, Lublin Branch)minorCOZL collaborates with the Lublin branch of the Polish Society of Laboratory Diagnostics for professional development and scientific exchange in medical diagnostics.
- Urząd Marszałkowski Województwa Lubelskiego (Marshal's Office of the Lublin Voivodeship)moderateCOZL operates as a regional healthcare institution under the Marshal's Office of the Lublin Voivodeship, which provides institutional oversight and funding coordination for regional healthcare facilities.
- Narodowy Fundusz Zdrowia (NFZ) — Lublin BranchcoreCOZL's primary public healthcare contracts are with the National Health Fund (NFZ), Lublin branch, which funds the vast majority of oncology services provided to entitled Polish citizens.
- Klinika Hematologii, Onkologii i Transplantologii Dziecięcej Uniwersyteckiego Szpitala Dziecięcego w Lublinie (Pediatric Hematology, Oncology and Transplantology Clinic of the University Children's Hospital in Lublin)moderateCollaboration for pediatric radiotherapy: COZL provides radiotherapy services for children with cancer from the University Children's Hospital, with qualification determined within multidisciplinary teams.
- Klinika Neurochirurgii i Neurochirurgii Dziecięcej SPSK4 w Lublinie (Neurosurgery and Pediatric Neurosurgery Clinic, SPSK4, Lublin)moderateLong-standing collaboration in stereotactic radiosurgery: the neurosurgery clinic and COZL have cooperated for many years in radiochirurgia, enabling innovative treatment of oncological and other conditions with benefits for patients.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Centrum Onkologii Ziemi Lubelskiej competitors and assessment
Company assessmentBroad incumbents
- Maria Skłodowska-Curie National Research Institute of Oncology (Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie): Poland's flagship national oncology center operating both Warsaw and Gliwice sites, providing comprehensive cancer care, research, and postgraduate training. Directly comparable to COZL in offering full-spectrum oncology (surgery, radiotherapy, chemotherapy, diagnostics), but at a national rather than regional scale.
- Institut Gustave Roussy: Leading European comprehensive cancer center in Villejuif, France, integrating treatment, research, and teaching across all oncology specialties. Comparable to COZL in offering a single-site full-spectrum cancer care platform, though at far greater scale, research intensity, and international patient volume.
- European Institute of Oncology (Istituto Europeo di Oncologia, IEO): Milan-based comprehensive cancer center delivering multidisciplinary oncology treatment, research, and prevention with strong radiotherapy and surgical programs. Comparable to COZL in the integrated single-site model and emphasis on advanced radiotherapy technology, but at significantly larger international scale.
- The Royal Marsden NHS Foundation Trust: UK specialist cancer hospital providing comprehensive inpatient and outpatient oncology, radiotherapy, chemotherapy, and diagnostics with extensive research programs. Comparable to COZL as a dedicated single-disease oncology hospital with full modality coverage, though operating under NHS rather than NFZ funding and at much larger national scale.
- Helios Klinikum Berlin-Buch: Large German academic-affiliated hospital providing comprehensive oncology including surgery, radiotherapy, and systemic therapy, with deep radiotherapy and brachytherapy capabilities. Comparable to COZL in combining advanced radiotherapy infrastructure with a full-service cancer care offering, though part of a larger private hospital group rather than a regional public monopoly.
Direct peers
- Greater Poland Cancer Centre (Wielkopolskie Centrum Onkologii): Regional public oncology hospital in Poznań serving the Greater Poland (Wielkopolska) voivodeship with comprehensive inpatient and outpatient oncology, radiotherapy, chemotherapy, and diagnostic services. Most directly comparable peer to COZL given the similar regional referral-center role within Poland's NFZ-funded public oncology network.
- Holycross Cancer Centre (Świętokrzyskie Centrum Onkologii): Regional public oncology hospital in Kielce providing comprehensive cancer diagnosis and treatment under NFZ contracts. Comparable to COZL as another regional-level oncology referral center with inpatient wards, radiotherapy, and outpatient specialty clinics serving a defined Polish voivodeship.
- West Pomeranian Oncology Center (Zachodniopomorskie Centrum Onkologii): Public regional oncology hospital in Szczecin offering surgical, radiotherapy, chemotherapy, and diagnostic oncology services under NFZ contracts. Directly comparable to COZL as a regional comprehensive cancer center within Poland's public healthcare network.
- Lower Silesian Oncology Center (Dolnośląskie Centrum Onkologii): Public regional oncology hospital in Wrocław providing comprehensive cancer treatment including radiotherapy, chemotherapy, and surgical oncology under NFZ contracts. Comparable to COZL in scope, regional referral role, and public-payer funding model.
Others
- Elekta (radiotherapy systems vendor ecosystem): Swedish manufacturer of linear accelerators (including the Versa HD) and radiotherapy software used at COZL's teleradiotherapy unit. Adjacent ecosystem participant that supplies COZL's core radiotherapy fleet; not a peer in service delivery but central to COZL's technology stack and roadmap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Centrum Onkologii Ziemi Lubelskiej social profiles
Digital presenceCentrum Onkologii Ziemi Lubelskiej compliance and trust
Trust signalCompliance6 records
Centrum Onkologii Ziemi Lubelskiej financial estimates
Financial estimateRevenue estimate
Valuation estimate
Centrum Onkologii Ziemi Lubelskiej leadership team
Management profileNumber of profiles
Profiles17 records
Centrum Onkologii Ziemi Lubelskiej funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Centrum Onkologii Ziemi Lubelskiej M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Centrum Onkologii Ziemi Lubelskiej
What does Centrum Onkologii Ziemi Lubelskiej do?
Centrum Onkologii Ziemi Lubelskiej is a public oncology hospital providing comprehensive cancer diagnosis, treatment, and follow-up care. Services include surgical oncology, radiotherapy (teleradiotherapy, brachytherapy, stereotactic radiosurgery), chemotherapy, nuclear medicine, diagnostic imaging (MRI, CT, PET, ultrasound, mammography), clinical pathology, genetics, rehabilitation, and palliative care, delivered across inpatient wards, outpatient specialist clinics, and diagnostic departments at its Lublin campus.
Is Centrum Onkologii Ziemi Lubelskiej a public or private company?
Centrum Onkologii Ziemi Lubelskiej is a public company. It is classified as state government owned and is currently operating.
When was Centrum Onkologii Ziemi Lubelskiej founded?
Centrum Onkologii Ziemi Lubelskiej was founded in 1953. It employs 1,001 to 5,000 people.
Where is Centrum Onkologii Ziemi Lubelskiej based?
Centrum Onkologii Ziemi Lubelskiej is headquartered in Lublin, Poland, in the Europe region.
How does Centrum Onkologii Ziemi Lubelskiej make money?
Three revenue lines are on record. National Health Fund (NFZ) Contracts are the primary driver. The others are fee-for-Service for Non-Entitled Patients and medical Diagnostic and Laboratory Services.
Who are Centrum Onkologii Ziemi Lubelskiej's main competitors?
Broad incumbents on record are Maria Skłodowska-Curie National Research Institute of Oncology (Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie), Institut Gustave Roussy, European Institute of Oncology (Istituto Europeo di Oncologia, IEO), The Royal Marsden NHS Foundation Trust and Helios Klinikum Berlin-Buch. Direct peers are Greater Poland Cancer Centre (Wielkopolskie Centrum Onkologii), Holycross Cancer Centre (Świętokrzyskie Centrum Onkologii), West Pomeranian Oncology Center (Zachodniopomorskie Centrum Onkologii) and Lower Silesian Oncology Center (Dolnośląskie Centrum Onkologii). Elekta (radiotherapy systems vendor ecosystem) is listed as an others.
Does Centrum Onkologii Ziemi Lubelskiej have an API?
No public API is recorded for Centrum Onkologii Ziemi Lubelskiej.
What industry is Centrum Onkologii Ziemi Lubelskiej in?
Centrum Onkologii Ziemi Lubelskiej's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 6223 and its SIC code is 8060.